USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
Missouri Master Naturalists, Chert Glades Chapter, will host an informational meeting for anyone interested in joining the fall Missouri Master Naturalists training class.
FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results